Kelly Dunn, Ph.D. is an Associate Professor in the Behavioral Pharmacology Research Unit in the Department of Psychiatry and Behavioral Sciences at Johns Hopkins University. Her research interests include mechanisms underlying opioid use disorder and development of effective treatment strategies, comorbid conditions in persons with opioid use disorder, and opioid overdose. Her research also includes randomized controlled evaluations of medications for alcohol use disorder and tobacco use, as well as development of standardized outcome measures.

Benjamin Han MD, MPH is an internist and board-certified in addiction medicine and geriatric medicine, an Associate Professor in the Division of Geriatrics, Gerontology, and Palliative Care at the University of California San Diego, and a primary care physician at the VA San Diego Healthcare System. His research focuses on psychoactive substance use among older adults and the development of care models that integrate the principles of geriatric medicine, addiction medicine, and harm reduction to improve the health of adults living with substance use disorders and co-occurring chronic medical diseases.

Ismene L. Petrakis, M.D. is an addiction psychiatrist, a Professor of Psychiatry at the Yale University School of Medicine and the Chief of Psychiatry and Mental Health Services at VA Connecticut Healthcare System.  She is also the Director of the Addiction Psychiatry Residency at Yale University School of Medicine and the principal investigator of a National Institute of Drug Abuse (NIDA-T32) training grant. She is certified by the American Board of Psychiatry and Neurology and Addiction Psychiatry.

Marcela Smid MD, MA, MS is a board certified Maternal Fetal Medicine and Addiction Medicine physician at the University of Utah. She is the medical director of the Substance Use & Pregnancy – Recovery, Addiction, Dependence (SUPeRAD) specialty prenatal clinic. She was an NIH K12Women’s Reproductive Health Research (WRHR) Program scholar.  Her research focus is on perinatal addiction, care models for pregnant and postpartum women with substance use disorders, maternal mortality, and maternal mental health.

Frank J. Vocci, PhD, is President and Senior Research Scientist of Friends Research Institute in Baltimore, Maryland. He has previously served as Director of the National Institute on Drug Abuse’s Division of Pharmacotherapies and Medical Consequences of Drug Abuse and is a Fellow and Past-President of The College on Problems of Drug Dependence.  His research interests include developing medications for treating nicotine and stimulant use disorder, developing new treaments for opioid use disorder, and evaluating best practices for treatment of opiate users with criminal justice involvement.